![](/img/cover-not-exists.png)
Considerations for a business model for the effective integration of novel biomarkers into drug development
Frueh, Felix WVolume:
5
Language:
english
Journal:
Personalized Medicine
DOI:
10.2217/17410541.5.6.641
Date:
November, 2008
File:
PDF, 1.43 MB
english, 2008